Invitae Reports Preliminary 2021 Revenue of More Than $458 Million and Billable Volume of More Than 1.16 Million
- Monday, January 10, 2022, 7:01
- Finance
- Add a comment
SAN FRANCISCO, Jan. 10, 2022 /PRNewswire/ — Invitae Corporation (NYSE: NVTA), a leading medical genetics company, announced preliminary unaudited full-year 2021 revenue, billable volume and commercial metrics reporting approximately 64 percent growth in revenue and 76 percent growth in…
About the Author
adminasapcorp has written 39635 stories on this site.